QuickVaccine: Technological innovation for adult immunization in Spain
Home News QuickVaccine: Technological innovation for adult immunization in Spain

QuickVaccine: Technological innovation for adult immunization in Spain

JUNE 14, 2024 BHH Members Initiatives

Adult vaccination rates in Spain are worryingly low, with only 30% vaccinated against pneumococcus and less than 50% against seasonal flu. This situation poses a serious challenge to public health, increasing the incidence of preventable diseases and healthcare costs.

In response to this problem, the Ramón y Cajal Hospital and the Ramón y Cajal Institute for Health Research (IRYCIS) developed QuickVaccine in collaboration with BHH member GooApps. QuickVaccine is an innovative application designed to improve adult vaccination coverage through personalized recommendations based on factors such as age, location, and health conditions.

The article describes the creation process of QuickVaccine, from identifying the need to improve adult vaccination to implementing advanced technological solutions. The collaboration between the hospital, IRYCIS, and GooApps has been key to the project's success, resulting in an application that not only informs but also motivates users to proactively manage their preventive health.

QuickVaccine uses an algorithm that generates personalized vaccination recommendations and features an intuitive user interface. Additionally, it includes functionalities such as personalized notifications, detailed information about vaccines, and a vaccination history log. The application has proven effective in improving vaccination rates and facilitating public health management.

Since its launch, QuickVaccine has received positive feedback from both users and medical professionals. The application has significantly improved vaccination management efficiency at the Ramón y Cajal Hospital and has the potential to be adopted nationally to address disparities in vaccination coverage.

GooApps has played a crucial role not only in technological development but also in the continuous promotion and support of the application. The collaboration has positioned QuickVaccine as an indispensable tool in preventive medicine, offering a scalable and adaptable solution to improve public health in Spain.

December 20, 2024 BHH Members Initiatives
Join the Pallapupas Christmas Raffle and bring smiles to Hospitals
By joining this raffle, participants will directly support a cause that uplifts the lives of patients and families when they need it most
Read more
December 17, 2024 BHH Members Initiatives
Join the Metastasis Challenge to find a cure for cancer
This initiative calls society to action in the fight against metastasis.
Read more
December 17, 2024 BHH Members Initiatives
Support hospitals with meaningful gifts this Christmas
In a year filled with challenges, what better way to embrace the holiday spirit than by choosing gifts with a purpose?
Read more
December 16, 2024 BHH Members Initiatives
Join the Tech4Eva 2025 Call for Application
Join the growing Femtech community of Tech4Eva and apply to this 6-month game changing global and virtual accelerator starting in May 2025
Read more
December 12, 2024 BHH Members Initiatives
Imaginae is transforming healthcare with AI and end-to-end digital solutions
Imaginae’s offerings include expertise in cloud solutions and IoT (Internet of Things), focusing on connected devices for eHealth.
Read more
December 11, 2024 BHH Members Initiatives
Maximizing the Potential of Remote Talent: Management, Communication, and Cultural Diversity
In a world where global connectivity is more accessible than ever, companies have the opportunity to tap into a borderless talent market.
Read more
December 03, 2024 BHH Members Initiatives
Barça Innovation Hub joins Genomcore shareholders
Barça Innovation Hub (BIHUB) co-invests alongside US-based investment firm QVIDTVM to support Genomcore’s expansion in biomedical data management and sports innovation.
Read more
November 25, 2024 BHH Members Initiatives
VB Devices expands its international presence with VARIXIO to over 30 countries
VB Devices will have expanded its international presence with VARIXIO to over 30 countries by the end of 2024. 
Read more
November 18, 2024 BHH Members Initiatives
Virtuleap launches Cogniclear VR for early cognitive screening
Cogniclear VR immerses users in realistic virtual environments to deliver more precise, objective evaluations of cognitive function.
Read more
November 13, 2024 BHH Members Initiatives
Participate in the lottery to mitigate pharmaceutical poverty
Once again Banco Farmacéutico sells lottery tickets in order to mitigate pharmaceutical poverty.
Read more